{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:37:35Z","timestamp":1773142655526,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T00:00:00Z","timestamp":1190764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00467-007-0618-8","type":"journal-article","created":{"date-parts":[[2007,9,25]],"date-time":"2007-09-25T12:27:43Z","timestamp":1190723263000},"page":"333-334","source":"Crossref","is-referenced-by-count":15,"title":["Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker"],"prefix":"10.1007","volume":"23","author":[{"given":"Claudio","family":"Celentano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Prefumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"di Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Iannicco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide Pio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,26]]},"reference":[{"key":"618_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.18553\/jmcp.2006.12.8.649","volume":"12","author":"CE Cooke","year":"2006","unstructured":"Cooke CE, Fatodu H (2006) Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a Medicaid managed care organization. J Manag Care Pharm 12:649\u2013655","journal-title":"J Manag Care Pharm"},{"key":"618_CR2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","volume":"3","author":"PG Pryde","year":"1993","unstructured":"Pryde PG, Sedman AB, Nugent CE, Barr M Jr (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575\u20131582","journal-title":"J Am Soc Nephrol"},{"key":"618_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","volume":"357","author":"H Saji","year":"2001","unstructured":"Saji H, Yamanaka M, Hagiwara A, Ijiri R (2001) Losartan and fetal toxic effects. Lancet 357:363","journal-title":"Lancet"},{"key":"618_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.20102","volume":"73","author":"S Alwan","year":"2005","unstructured":"Alwan S, Polifka JE, Friedman JM (2005) Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 73:123\u2013130","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"618_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00467-006-0070-1","volume":"21","author":"F Daikha-Dahmane","year":"2006","unstructured":"Daikha-Dahmane F, Levy-Beff E, Jugie M, Lenclen R (2006) Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol 21:729\u2013732","journal-title":"Pediatr Nephrol"},{"key":"618_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","volume":"82","author":"A Quan","year":"2006","unstructured":"Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23\u201328","journal-title":"Early Hum Dev"},{"key":"618_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00045391-200107000-00010","volume":"8","author":"J Prandota","year":"2001","unstructured":"Prandota J (2001) Clinical pharmacology of furosemide in children: a supplement. Am J Ther 8:275\u2013289","journal-title":"Am J Ther"},{"key":"618_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0002-9378(12)90923-0","volume":"168","author":"TF Kelly","year":"1993","unstructured":"Kelly TF, Moore TR, Brace RA (1993) Hemodynamic and fluid responses to furosemide infusion in the ovine fetus. Am J Obstet Gynecol 168:260\u2013268","journal-title":"Am J Obstet Gynecol"},{"key":"618_CR9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0002-9378(95)91350-5","volume":"173","author":"NJ Flack","year":"1995","unstructured":"Flack NJ, Sepulveda W, Bower S, Fisk NM (1995) Acute maternal hydration in third-trimester oligohydramnios: effects on amniotic fluid volume, uteroplacental perfusion, and fetal blood flow and urine output. Am J Obstet Gynecol 173:1186\u20131191","journal-title":"Am J Obstet Gynecol"},{"key":"618_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000082428","volume":"20","author":"T Iura","year":"2005","unstructured":"Iura T, Makinoda S, Fujita S, Matsuzawa S, Waseda T, Oshima K, Tomizawa H (2005) Analysis of the renal artery hemodynamics in normal fetuses using the color Doppler method. Fetal Diagn Ther 20:86\u201390","journal-title":"Fetal Diagn Ther"},{"key":"618_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/tera.1420500606","volume":"50","author":"M Barr","year":"1994","unstructured":"Barr M (1994) Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50:399\u2013409","journal-title":"Teratology"},{"key":"618_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/tera.1420510603","volume":"51","author":"SG Spence","year":"1995","unstructured":"Spence SG, Allen HL, Cukierski MA, Manson JM, Robertson RT, Eydelloth RS (1995) Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:367\u2013382","journal-title":"Teratology"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-007-0618-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0618-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T07:12:22Z","timestamp":1629789142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-007-0618-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,26]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0618-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,26]]}}}